Is Hester Biosciences the Best Stock in Its Sector? A Look at the Numbers
- September 28, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Hester Biosciences CMP Rs 2,165 (28 Sep 2026). Market cap Rs 1,858 Cr. ROE 15.45%. P/E 13.57x versus Industry P/E 38.42x.
Quick Answer
Hester Biosciences is one of the names investors compare when screening the Healthcare sector, built on a 15.45% return on equity and a P/E of 13.57x against an Industry P/E of 38.42x. Whether Hester Biosciences is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Hester Biosciences the best stock in its sector? The stock trades on the NSE at Rs 2,165 as of 28 September 2026, within its 52-week range of Rs 1,239.30 to Rs 2,683.60. Hester Biosciences Ltd makes poultry and livestock vaccines and animal health products.
Hester Biosciences sits in the Healthcare sector, and its 15.45% ROE and 13.57x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Hester Biosciences
Hester Biosciences Ltd makes poultry and livestock vaccines and animal health products. The stock trades at a very high absolute price with low daily volumes. At a market capitalisation of Rs 1,858 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Hester Biosciences the Best Stock in Its Sector?
Hester Biosciences makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 15.45% ROE with a 13.57x P/E against the sector’s 38.42x Industry P/E. Hester Biosciences’ 13.57x P/E is far below the 38.42x Industry P/E despite a 15.45% ROE, though the benchmark is for human healthcare names and trading volumes in the stock are low.
| Metric | Hester Biosciences |
|---|---|
| CMP (NSE) | Rs 2,165.00 |
| 52-Week High / Low | Rs 2,683.60 / Rs 1,239.30 |
| Market Cap | Rs 1,858 Cr |
| P/E (TTM) vs Industry P/E | 13.57x vs 38.42x |
| P/B | 5.16 |
| ROE | 15.45% |
| EPS (TTM) | Rs 160.95 |
| Dividend Yield | 0.50% |
| Debt to Equity | 0.54 |
Compare Hester Biosciences Against Other Healthcare Sector Stocks
How Hester Biosciences Compares Against Its Healthcare Sector Peers
The table below sets Hester Biosciences against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Hester Biosciences | 1,858 | 13.57 | 15.45% | 0.54 |
| Gufic Biosciences | 4,224 | 57.55 | 9.66% | 0.61 |
| CORONA Remedies | 13,237 | 66.51 | 24.79% | 0.22 |
| Peer average (2 companies) | – | 62.03 | 17.23% | 0.41 |
Against this peer set, Hester Biosciences’s 15.45% ROE is below the 17.23% peer average, and its P/E of 13.57x runs below the peer average of 62.03x. Hester Biosciences’ 13.57x P/E is far below the 38.42x Industry P/E despite a 15.45% ROE, though the benchmark is for human healthcare names and trading volumes in the stock are low.
What Makes Hester Biosciences Worth Watching in Healthcare
- Well below Industry P/E: A 13.57x P/E against a 38.42x Industry P/E is a wide discount for a business with a 15.45% ROE.
- Strong ROE: A 15.45% ROE is a healthy figure for an animal health company.
- Animal health niche: Poultry and livestock vaccines are a specialised segment compared with human pharma formulations.
Hester Biosciences Valuation: Is It Justified?
Hester Biosciences’ 13.57x P/E is far below the 38.42x Industry P/E despite a 15.45% ROE, though the benchmark is for human healthcare names and trading volumes in the stock are low. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Godrej Agrovet the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Hester Biosciences and other Healthcare sector stocks.
How to Track Hester Biosciences Before You Invest
Before deciding whether Hester Biosciences deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Hester Biosciences to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Hester Biosciences earns a place in the best stock in its sector conversation on the strength of a 15.45% ROE and a P/E of 13.57x against a 38.42x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Hester Biosciences the best stock in its sector?
Ans. Hester Biosciences has a 15.45% ROE and trades at 13.57x P/E against a 38.42x Industry P/E, and compares below the peer average ROE of 17.23% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Hester Biosciences?
Ans. Hester Biosciences was trading at Rs 2,165.00 on the NSE as of 28 September 2026, within its 52-week range of Rs 1,239.30 to Rs 2,683.60.
What sector does Hester Biosciences belong to?
Ans. Hester Biosciences is classified under the Healthcare sector on Univest.
How does Hester Biosciences compare to its sector peers on P/E?
Ans. Hester Biosciences’s P/E of 13.57x is below the 62.03x average of the 2 named peers compared in this article.
What is Hester Biosciences’s return on equity?
Ans. Hester Biosciences reported a return on equity of 15.45%, which is below the 17.23% average of its named peers in this comparison.
Should I invest in Hester Biosciences based on its sector position?
Ans. Hester Biosciences’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
